35 U.S.C. § 271(e)(1)
Definition
Part of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Amendments) that recognizes a research infringement exception for drug and medical device innovators solely for the purposes of submitting information to the Food and Drug Administration.